on March 29, 2013 |
Permalink
| Comments (1)
Topics: Cardiovascular, Service Lines, Primary Care, Chronic Care Management, Methodologies, Performance Improvement, Patient-Focused Care, Care Transformation, Medical Home, Physician Issues
Megan Tooley, Cardiovascular Roundtable
This week, the National Committee for Quality Assurance (NCQA) launched a recognition program that aims to extend its successful Patient-Centered Medical Home (PCMH) model beyond primary care to specialty practices. The new Patient-Centered Specialty Practice (PCSP) designation program provides clear guidelines for specialists looking to establish a role in patient-centered “medical neighborhoods,” and will recognize practices committed to providing team-based, coordinated care and enhancing communication with providers and patients across the continuum.
Continue reading:
Specialists get a shot at patient-centered medical home model
on January 11, 2013 |
Permalink
Topics: Cardiovascular, Service Lines, Palliative Care, Methodologies, Performance Improvement
Brian Maher, Cardiovascular Roundtable
As providers seek to promote patient-centeredness in a value-based delivery system, palliative care will be a critical offering that has far-reaching implications across multiple service lines.
For CV services especially, palliative care is an integral component of the care continuum, often with focus on preventing readmissions for susceptible patients, such as those with heart failure. For example, Parkview Heart Institute leverages a home health coordinator to ensure heart failure patients discharged home are receiving the correct post-acute strategy, including palliative care, based upon their risks. Like Parkview, Lehigh Valley’s outpatient palliative care service has led to substantial reductions in hospitalizations and variable costs per hospitalization.
Continue reading:
How to advance palliative care at your institution
on October 31, 2012 |
Permalink
Topics: Cardiovascular, Service Lines, Outcomes, Quality, Performance Improvement, Technology Assessment, Methodologies
Megan Tooley, Cardiovascular Roundtable
The latest results of the PARTNER Cohort B trial, recently presented at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Miami, demonstrate that the mortality benefits of transcatheter aortic valve replacement (TAVR) in inoperable patients are maintained out to at least three years.
Furthermore, the data provide insight into the impact of comorbidities at the time of implant on outcomes, further emphasizing the importance of careful patient selection for TAVR.
Continue reading:
TAVR outcomes remain strong at three years
